1. Israel Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Shl Telemedicine Ltd.

Shl Telemedicine Ltd.

1.07
CHF
0.00
(0.00%)
0.04EPS
124.32P/E
102.81MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.57
2.1
1.95
2.13
1.96
2.56
2.19
2.1
1.93
2.21
1.93
1.91
2.74
2.01
Basic EPS, GAAP
0.12
0.04
-0.83
-0.58
0.13
0.53
0.3
0.01
-0.55
- -
-0.24
-0.94
-0.72
0.05
Free Cash Flow per Basic Share
-0.08
-0.39
0.06
-0.12
0.54
0.6
0.46
0.15
-0.12
-0.26
-0.24
-0.14
-0.23
0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
0.55
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
3.63
2.73
1.79
1.25
1.53
2.05
1.83
1.98
2.16
2.09
2.47
1.32
1.18
3.21
Tangible Book Value per Share
1.88
1.22
0.16
-0.1
0.15
0.81
0.64
0.79
-0.05
0.06
0.68
0.15
0.3
1.41
Basic Weighted Avg Shares
19
19
19
19
19
19
19
19
26
27
30
30
21
20
Sales/Revenue/Turnover
30
40
37
41
37
49
42
40
50
59
57
57
59
40
Operating Margin (%)
-18.18
2.87
-21.32
-2.43
3.43
24.23
13.64
2.35
0.1
-8.05
-11.93
-12.44
-7.69
5.05
Depreciation Expense
5
6
5
6
5
4
4
5
5
7
8
8
7
- -
Net Income, GAAP
2
1
-16
-11
2
10
6
- -
-14
- -
-7
-28
-15
1
Effective Tax Rate (%)
- -
55.26
- -
- -
20.11
11.55
- -
- -
- -
83.61
- -
- -
- -
50.4
Profit Margin (%)
7.52
2.07
-42.44
-27.37
6.44
20.75
13.6
0.69
-28.46
-0.13
-12.36
-49.48
-26.2
2.31
Working Capital
28
20
- -
-1
-5
7
1
3
28
14
23
1
7
16
LT Debt
18
13
9
10
1
- -
11
11
28
22
15
12
9
12
Total Equity
69
52
34
24
29
38
35
38
61
59
76
39
44
61
Return on Invested Capital (%)
- -
0.71
- -
- -
6.39
21.36
- -
- -
- -
-0.93
- -
- -
- -
0.83
Return on Capital (%)
- -
1.44
- -
- -
7.26
25.37
- -
- -
- -
-0.22
- -
- -
- -
1.74
Return on Common Equity (%)
3.44
1.37
-36.56
-38.25
9.08
30.32
15.73
0.77
-29.79
-0.14
-10.92
-49.82
-37.04
1.43

Capital Structure

USD

•

in mil. unless spec.
Dec'14
Mar'15
Jun'15
ST Debt
10
10
11
LT Borrowings
13
12
12
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
19
19
Market Capitalization
95
89
110

Working Capital

USD

•

in mil. unless spec.
Dec'14
Mar'15
Jun'15
Total Current Assets
36
34
36
Cash, Cash Equivalents & STI
17
9
13
Accounts Receivable, Net
7
17
15
Inventories
2
2
3
Total Current Liabilities
16
18
20
Payables & Accruals
6
6
7
ST Debt
10
10
11
Deferred Revenue
- -
2
2

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.23%
9.96%
11.52%
Free Cash Flow
-101.64%
-19.95%
20.89%
Net Income, GAAP
419.31%
832.42%
-45.27%
Sales/Revenue/Turnover
5.59%
8.41%
3.37%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
57
2024
- -
- -
57
2025
- -
- -
59

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.24
2024
- -
- -
-0.94
2025
- -
- -
-0.72

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
David Arnon
Full Time Employees
526
Sector
Health services
Industry
Medical/Nursing services
Address
Ashdar Building Tel Aviv TA Israel 6789130
IPO Date
Nov 15, 2000
Website
shl-telemedicine.com
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
SHL Telemedicine Ltd. develops and markets personal telemedicine solutions focused on remote monitoring and diagnosis of cardiovascular and chronic conditions; it provides devices such as SmartHeart, a mobile 12-lead ECG for heart attack detection; CardioSen’C, a cellular-digital 12-lead ECG transmitter; Cardio’B, a portable 12-lead ECG device; TelePress, a remote blood pressure monitor; central communication modules integrating data from blood pressure, weight scales, TelePulse Oximeter for oxygen saturation, TeleBreather for breath exhalation, and glucose meters; and telemedicine services including congestive heart failure monitoring, COPD management, and medical call center support delivered via electronic and telecommunication technologies. The company serves physicians, hospitals, health insurance funds, and patients in Israel, Europe including Germany, and internationally from its headquarters at Ashdar Building, 90 Yigal Alon Street, Tel Aviv, Israel, where it was founded in 1987. SHL Telemedicine maintains collaborations with Mayo Clinic for SmartHeart post-heart attack evaluation, Hebrew University of Jerusalem, and Hadassah Medical Center; recent SEC filings reflect ongoing operational reports and employee securities registrations as of early 2025, with no major acquisitions or funding rounds announced in the past two years.